Learn about our healthcare areas

Explore medicine and therapy products
Explore MedTech products

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

Listening...

Search Results

No Results

    See all results

    Sorry, I don't understand. Please try again
    1. Home/
    2. News/
    3. Innovation/
    4. Innovation-opedia: What is a mosaic vaccine?
    Graphic featuring a syringe to illustrate an HIV vaccine trial
    Innovation

    Innovation-opedia: What is a mosaic vaccine?

    As the IAS Conference on HIV Science kicks off in Mexico City, we explain how an investigational HIV vaccine from the Janssen Pharmaceutical Companies of Johnson & Johnson works—and how researchers hope to help change lives around the world with it.

    Written by Johnson & Johnson
     | July 22, 2019
    July 22, 2019
    Illustrated handwritten definition of a mosaic HIV vaccine
    Illustration of a microscope with information about Janssen Vaccines & Prevention B.V. investigational HIV-1 vaccine regimen
    Inset- Innovation-opedia: What Is a Mosaic Vaccine?- mosaic-vaccine-4-immunizations_above
    Illustration of the # 4 explaining how many injections would be administered for Janssen’s investigational HIV-1 vaccine.
    Inset- Innovation-opedia: What Is a Mosaic Vaccine?- mosaic-vaccine-4-immunizations_below
    Illustration showing location of the IAS Conference on HIV Science with details about Janssen’s new Mosaico clinical trial.
    Illustrated quote by Janssen’s Maria Grazia Pau talking about the goal of creating a global HIV vaccine.

    We’re committed to helping lead the fight against HIV/AIDS

    Read about the many ways Johnson & Johnson is working to #makeHIVhistory.
    Learn more
    CTA-Red ribbon HIV

    HIV vaccine J&J Innovative Medicine Johnson & Johnson

    More from Johnson & Johnson

    Innovation
    January 29, 2026

    Shockwave: Inside the development of a cutting-edge system to treat coronary artery disease

    Johnson & Johnson’s Patrick Stephens explains how innovative technology using ultrasonic acoustic pressure waves has made the treatment of certain types of cardiovascular disease easier for doctors and safer for patients.
    Read more
    Health & wellness
    January 27, 2026

    What is asthma?

    This chronic inflammatory disease causes flareups that make it difficult to breathe. Learn about the two types of asthma, common triggers and how Johnson & Johnson is developing approaches that may lead to better treatments.
    Read more
    Latest news
    January 26, 2026

    Johnson & Johnson named a 2026 Fortune World’s Most Admired Company

    The company made the prestigious list for the 24th consecutive year, thanks to its dedication to innovation and social responsibility, among other criteria.
    Read more